We are live on ! Find out more
PDLI

PDL BioPharma, Inc.
PDLI

Delisted

PDLI was delisted on the 30th of December, 2020.

Back to rankings

186 hedge funds and large institutions have $466M invested in PDL BioPharma, Inc. in 2017 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 63 increasing their positions, 44 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

138% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 13

45% more capital invested

Capital invested by funds: $321M → $466M (+$145M)

43% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 44

9% more funds holding

Funds holding: 171 → 186 (+15)

37% less call options, than puts

Call options by funds: $450K | Put options by funds: $717K

Holders
186
Holders Change
+15
Holders Change %
+8.77%
% of All Funds
4.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
63
Reduced
44
Closed
13
Calls
$450K
Puts
$717K
Net Calls
-$267K
Net Calls Change
-$555K

Top Buyers

1
Millennium Management
Millennium Management
New York
+$8.55M
2
Morgan Stanley
Morgan Stanley
New York
+$6.49M
3
State Street
State Street
Massachusetts
+$5.81M
4
Mackenzie Financial
Mackenzie Financial
Ontario, Canada
+$3.96M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$3.56M

Top Sellers

1
Citadel Advisors
Citadel Advisors
Florida
-$9.56M
2
Bank of America
Bank of America
North Carolina
-$4.6M
3
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board
Ontario, Canada
-$3.61M
4
BlackRock
BlackRock
New York
-$2.18M
5
Deutsche Bank
Deutsche Bank
Germany
-$2M
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
51
Sterling Capital Management
North Carolina
$1.17M – – –
MCM
52
McKinley Capital Management
Alaska
$1.11M +$13.9K +5,011 +2%
HIM
53
Hillsdale Investment Management
Ontario, Canada
$1.06M +$872K +313,507 New
TA
54
Teachers Advisors
New York
$1.01M -$15K -5,377 -2%
Credit Agricole
55
Credit Agricole
France
$950K +$640K +230,000 +460%
California State Teachers Retirement System (CalSTRS)
56
California State Teachers Retirement System (CalSTRS)
California
$862K -$76.3K -27,438 -10%
Macquarie Group
57
Macquarie Group
Australia
$851K +$698K +251,140 New
AllianceBernstein
58
AllianceBernstein
Tennessee
$845K -$72.9K -26,200 -10%
Swiss National Bank
59
Swiss National Bank
Switzerland
$838K – – –
SO
60
STRS Ohio
Ohio
$749K -$144K -51,900 -19%
Citadel Advisors
61
Citadel Advisors
Florida
$745K -$9.56M -3,439,309 -94%
SCA
62
Secor Capital Advisors
New York
$742K -$502K -180,594 -45%
FIM
63
Freedom Investment Management
Connecticut
$738K -$42.7K -15,356 -7%
AG
64
Aperio Group
California
$735K +$1.93K +695 +0.3%
Canada Pension Plan Investment Board
65
Canada Pension Plan Investment Board
Ontario, Canada
$727K -$3.61M -1,299,138 -86%
RhumbLine Advisers
66
RhumbLine Advisers
Massachusetts
$706K +$7.22K +2,596 +1%
RC
67
RBF Capital
California
$602K – – –
DekaBank Deutsche Girozentrale
68
DekaBank Deutsche Girozentrale
Germany
$549K – – –
New York State Common Retirement Fund
69
New York State Common Retirement Fund
New York
$526K – – –
SAM
70
Shell Asset Management
Netherlands
$524K -$10K -3,600 -2%
AIMCA
71
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$521K – – –
CCMH
72
Cornerstone Capital Management Holdings
New York
$518K +$21.1K +7,600 +5%
Bank of America
73
Bank of America
North Carolina
$516K -$4.6M -1,653,107 -92%
Fidelity Investments
74
Fidelity Investments
Massachusetts
$515K -$1.11M -399,689 -72%
JMPWA
75
JP Morgan Private Wealth Advisors
California
$481K – – –
1 2
3
4 5

PDLI Hedge Fund Activity: Q3 2017 in Review

186 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in PDL BioPharma, Inc. (PDLI) for Q3 2017, worth a combined $466M — up 45% from $321M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new PDLI positions and 13 closed out — a net gain of 18 holders — while 63 added to existing stakes and 44 trimmed.

The largest buyer was Millennium Management, adding an estimated $8.55M. The largest seller was Citadel Advisors, cutting an estimated $9.56M.

  • 186 institutional investors held PDL BioPharma, Inc. (PDLI) as of Q3 2017, up from 171 in Q2 2017.
  • Funds reported $466M of PDL BioPharma, Inc. stock for Q3 2017, up 45% quarter-over-quarter.
  • 31 funds opened new PDL BioPharma, Inc. positions in Q3 2017 and 13 closed out, a net change of +18 holders.
  • The largest PDL BioPharma, Inc. buyer in Q3 2017 was Millennium Management, an estimated $8.55M added.
  • The largest PDL BioPharma, Inc. seller in Q3 2017 was Citadel Advisors, an estimated $9.56M sold.

Based on aggregated 13F filings for Q3 2017.